Dômes Pharma announces that it has finalized the acquisition of SentrX Animal Care, a US company based in Salt Lake City (Utah). SentrX develops and manufactures ophthalmology products based on its exclusive BioHAnce™ technology. BioHAnce™ is a patented crosslinked Hyaluronic Acid technology that enhances and accelerates natural healing, hydration and lubrication processes, while reducing the number of applications. The company, which has its own 2,000 m2 manufacturing plant, markets 3 products that have rapidly gained market share in the United States and Europe, notably in the UK, thanks to their effectiveness and ease of use.
Read the full article: Dômes Pharma Acquires Sentrx Animal Care, Inc. //
Source: https://www.prnewswire.com/news-releases/with-the-acquisition-of-sentrx-animal-care-inc-domes-pharma-expands-its-global-leadership-in-veterinary-ophthalmology-while-creating-a-launching-pad-for-its-therapeutic-product-franchises-in-north-america-301902108.html